Beurel, Eléonore <br/><br/>
GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.  [electronic resource] 

 -  Experimental cell research  Nov 2004 
 - 354-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4827 
<br/><br/><label>Standard No.: </label>10.1016/j.yexcr.2004.08.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Camptothecin--pharmacology<br/>Etoposide--pharmacology<br/>Gene Expression Regulation--physiology<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Lithium--pharmacology<br/>Promoter Regions, Genetic--physiology<br/>Topoisomerase I Inhibitors<br/>Topoisomerase II Inhibitors<br/>Tumor Suppressor Protein p53--metabolism<br/>fas Receptor--biosynthesis